[go: up one dir, main page]

AU2003238930A1 - Enzymes - Google Patents

Enzymes

Info

Publication number
AU2003238930A1
AU2003238930A1 AU2003238930A AU2003238930A AU2003238930A1 AU 2003238930 A1 AU2003238930 A1 AU 2003238930A1 AU 2003238930 A AU2003238930 A AU 2003238930A AU 2003238930 A AU2003238930 A AU 2003238930A AU 2003238930 A1 AU2003238930 A1 AU 2003238930A1
Authority
AU
Australia
Prior art keywords
enzymes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003238930A
Other versions
AU2003238930A8 (en
Inventor
Shanya D. Becha
Sean A. Bulloch
Hsin-Ru Chang
Narinder K. Chawla
Vicki S. Elliott
Brooke M. Emerling
Kimberly J. Gietzen
April J.A. Hafalia
Phillip R. Hawkins
Pei Jin
Amy E. Kable
Reena Khare
Soo Y. Lee
Joseph P. Marquis
Patricia M. Mason
Thomas W. Richardson
Anita Swarnakar
Uyen K. Tran
Amy D. Wilson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Incyte Corp
Original Assignee
Incyte Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Incyte Corp filed Critical Incyte Corp
Publication of AU2003238930A8 publication Critical patent/AU2003238930A8/en
Publication of AU2003238930A1 publication Critical patent/AU2003238930A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/16Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/18Carboxylic ester hydrolases (3.1.1)
    • C12N9/20Triglyceride splitting, e.g. by means of lipase
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702Regulators; Modulating activity

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU2003238930A 2002-06-07 2003-06-05 Enzymes Abandoned AU2003238930A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US38711902P 2002-06-07 2002-06-07
US60/387,119 2002-06-07
US39066202P 2002-06-21 2002-06-21
US60/390,662 2002-06-21
PCT/US2003/017907 WO2003104410A2 (en) 2002-06-07 2003-06-05 Enzymes

Publications (2)

Publication Number Publication Date
AU2003238930A8 AU2003238930A8 (en) 2003-12-22
AU2003238930A1 true AU2003238930A1 (en) 2003-12-22

Family

ID=29739930

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003238930A Abandoned AU2003238930A1 (en) 2002-06-07 2003-06-05 Enzymes

Country Status (2)

Country Link
AU (1) AU2003238930A1 (en)
WO (1) WO2003104410A2 (en)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030027135A1 (en) 2001-03-02 2003-02-06 Ecker David J. Method for rapid detection and identification of bioagents
US7226739B2 (en) 2001-03-02 2007-06-05 Isis Pharmaceuticals, Inc Methods for rapid detection and identification of bioagents in epidemiological and forensic investigations
US20040121313A1 (en) 2002-12-06 2004-06-24 Ecker David J. Methods for rapid detection and identification of bioagents in organs for transplantation
US7666588B2 (en) 2001-03-02 2010-02-23 Ibis Biosciences, Inc. Methods for rapid forensic analysis of mitochondrial DNA and characterization of mitochondrial DNA heteroplasmy
US8073627B2 (en) 2001-06-26 2011-12-06 Ibis Biosciences, Inc. System for indentification of pathogens
US7217510B2 (en) 2001-06-26 2007-05-15 Isis Pharmaceuticals, Inc. Methods for providing bacterial bioagent characterizing information
CA2508726A1 (en) 2002-12-06 2004-07-22 Isis Pharmaceuticals, Inc. Methods for rapid identification of pathogens in humans and animals
US8057993B2 (en) 2003-04-26 2011-11-15 Ibis Biosciences, Inc. Methods for identification of coronaviruses
US7964343B2 (en) 2003-05-13 2011-06-21 Ibis Biosciences, Inc. Method for rapid purification of nucleic acids for subsequent analysis by mass spectrometry by solution capture
US8158354B2 (en) 2003-05-13 2012-04-17 Ibis Biosciences, Inc. Methods for rapid purification of nucleic acids for subsequent analysis by mass spectrometry by solution capture
US8097416B2 (en) 2003-09-11 2012-01-17 Ibis Biosciences, Inc. Methods for identification of sepsis-causing bacteria
US20120122103A1 (en) 2003-09-11 2012-05-17 Rangarajan Sampath Compositions for use in identification of bacteria
US8546082B2 (en) 2003-09-11 2013-10-01 Ibis Biosciences, Inc. Methods for identification of sepsis-causing bacteria
US8163895B2 (en) 2003-12-05 2012-04-24 Ibis Biosciences, Inc. Compositions for use in identification of orthopoxviruses
US7666592B2 (en) 2004-02-18 2010-02-23 Ibis Biosciences, Inc. Methods for concurrent identification and quantification of an unknown bioagent
EP1766659A4 (en) 2004-05-24 2009-09-30 Ibis Biosciences Inc SELECTIVE ION FILTRATION MASS SPECTROMETRY BY DIGITAL SINKING
US20050266411A1 (en) 2004-05-25 2005-12-01 Hofstadler Steven A Methods for rapid forensic analysis of mitochondrial DNA
US7811753B2 (en) 2004-07-14 2010-10-12 Ibis Biosciences, Inc. Methods for repairing degraded DNA
US8084207B2 (en) 2005-03-03 2011-12-27 Ibis Bioscience, Inc. Compositions for use in identification of papillomavirus
WO2006094238A2 (en) 2005-03-03 2006-09-08 Isis Pharmaceuticals, Inc. Compositions for use in identification of adventitious viruses
JP2009502137A (en) 2005-07-21 2009-01-29 アイシス ファーマシューティカルズ インコーポレイティッド Method for rapid identification and quantification of nucleic acid variants
EP2064332B1 (en) 2006-09-14 2012-07-18 Ibis Biosciences, Inc. Targeted whole genome amplification method for identification of pathogens
EP2126132B1 (en) 2007-02-23 2013-03-20 Ibis Biosciences, Inc. Methods for rapid foresnsic dna analysis
WO2008151023A2 (en) 2007-06-01 2008-12-11 Ibis Biosciences, Inc. Methods and compositions for multiple displacement amplification of nucleic acids
EP2344893B1 (en) 2008-09-16 2014-10-15 Ibis Biosciences, Inc. Microplate handling systems and methods
EP2347254A2 (en) 2008-09-16 2011-07-27 Ibis Biosciences, Inc. Sample processing units, systems, and related methods
US8550694B2 (en) 2008-09-16 2013-10-08 Ibis Biosciences, Inc. Mixing cartridges, mixing stations, and related kits, systems, and methods
US8158936B2 (en) 2009-02-12 2012-04-17 Ibis Biosciences, Inc. Ionization probe assemblies
EP2454000A4 (en) 2009-07-17 2016-08-10 Ibis Biosciences Inc Systems for bioagent identification
WO2011008971A1 (en) 2009-07-17 2011-01-20 Ibis Biosciences, Inc. Lift and mount apparatus
ES2628739T3 (en) 2009-10-15 2017-08-03 Ibis Biosciences, Inc. Multiple displacement amplification

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4409099A (en) * 1998-05-29 1999-12-13 Incyte Pharmaceuticals, Inc. Human transmembrane proteins

Also Published As

Publication number Publication date
AU2003238930A8 (en) 2003-12-22
WO2003104410A2 (en) 2003-12-18
WO2003104410A3 (en) 2004-11-11

Similar Documents

Publication Publication Date Title
AU2003238930A1 (en) Enzymes
AU2003274037A1 (en) 1-phenylpyrrolidine-2-one-3-carboxamides
AU2002357860A1 (en) Enzymes
AU2002952554A0 (en) Monitower
AU2003228139A1 (en) Bioreactor
AU2002347778A1 (en) Enzymes
AU2003272301A1 (en) Carotene-specific lipase
AU2003245747A1 (en) Enzymes
AU2003212773A1 (en) Boosterantenna
AU2003216376A1 (en) Enzymes
AU2003225282A1 (en) Enzymes
AU2003220607A1 (en) Enzymes
AU2002318053A1 (en) Suplier
AUPS282802A0 (en) Novel enzymes
AU2003294219A1 (en) Enzymes
AU2002257273A1 (en) Enzymes
AU2003242163A1 (en) Novel oxidase
AUPR482001A0 (en) Metal-handling enzymes
AU2002346709A1 (en) Cellulose-active microorganisms
AU2002100031A4 (en) earliPay
AU2002100160A4 (en) Oxidirator
AU2002100957A4 (en) Sluggit
AU2002100482A4 (en) Tail-gate-ezy
AU2002100739A4 (en) Neuramax
AU2002100510A4 (en) Bottlenecker

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase